ID | 117027 |
タイトル別表記 | Retroperitoneal hemorrhage with COVID-19
|
著者 |
Yoshioka, Takuya
Tokushima University
Tada, Kouki
Tokushima University
Mima, Masato
Tokushima University
|
キーワード | anticoagulants
COVID-19
nafamostat
retroperitoneal hemorrhage
TAE
|
資料タイプ |
学術雑誌論文
|
抄録 | Introduction: Early prophylactic administration of anticoagulants is recommended in patients with coronavirus disease 2019 (COVID-19). A case of retroperitoneal hemorrhage during inpatient treatment for COVID-19 is reported. Case Presentation : A 69-year-old man was diagnosed with COVID-19 6 days after symptom onset. After admission for difficulty of breathing, he was treated with steroid pulse therapy, remdesivir, and heparin sodium. On day 16 after admission, his hemoglobin and blood pressure dropped. Computed tomography showed a left retroperitoneal hematoma and multiple areas of extravasation in bilateral iliopsoas muscles. Anticoagulation therapy was stopped, and blood transfusion therapy was chosen by considering poor general condition caused by severe pneumonia. On day 19, the hemoglobin and blood pressure improved, and blood transfusion was stopped. However, he died on day 25 due to pneumonia. Conclusion : When retroperitoneal hemorrhage occurs as a complication of COVID-19, appropriate treatment decision, transcatheter arterial embolization or conservative treatment, should be chosen based on patient’s condition.
|
掲載誌名 |
The Journal of Medical Investigation
|
ISSN | 13496867
13431420
|
cat書誌ID | AA11166929
|
出版者 | Tokushima University Faculty of Medicine
|
巻 | 69
|
号 | 1-2
|
開始ページ | 148
|
終了ページ | 151
|
並び順 | 148
|
発行日 | 2022-02
|
EDB ID | |
出版社版DOI | |
出版社版URL | |
フルテキストファイル | |
言語 |
eng
|
著者版フラグ |
出版社版
|
部局 |
病院
医学系
|